AKARI THERAPEUTICS PLC-ADR

AKTXNASDAQ

🏆 #3824 by market capEarnings Aug 18US Equity

$7.73▲ $0.21 (+2.66%)

🌙 After hours$7.73▲ 0.00%Regular close · extended-hours price shown

1h—

24h▲ 2.7%

7d▲ 3.3%

14d▼ 8.5%

30d▼ 46.5%

1y▼ 82.1%

🏦Market Cap

$27.59B

Mid Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Weak

Trading Snapshot

Day Range: $7.63 – $7.79
52-Week Range: $3.02 – $49.60
Volume: $2.42B
Avg Volume: $2.44B
Shares Outstanding: 3.57B
Next Earnings: Oct 12, 2026

Fundamentals Snapshot

Annual Revenue: $2.65B
Last Q Revenue: $621M
P/E Ratio: —
P/S Ratio: —
EPS (TTM): $-0.01
Dividend Yield: —

Why Investors Own AKTX

✓High-growth profile — revenue up +44.9% YoY with expanding US Equity exposure.
✓Healthy economics — 77% gross margin and 14% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$2.65B▲ +42.3% YoY

Gross Margin (TTM)

76.5%▼ −0.2% YoY

Operating Income (TTM)

$462M▲ +42.3% YoY

Free Cash Flow (TTM)

$358M▲ +42.3% YoY

About AKARI THERAPEUTICS PLC-ADR

Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company’s lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, bladder, head and neck, gastric, pancreatic, colon, prostate, and others. Its payloads include PH1 is a novel payload that is a spliceosome modulator designed to disrupt RNA splicing within cancer cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Tampa, Florida.

🦦